Ekso Bionics Holdings Operating Income 2013-2024 | EKSO
Ekso Bionics Holdings operating income from 2013 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Ekso Bionics Holdings Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-15 |
| 2022 | $-16 |
| 2021 | $-14 |
| 2020 | $-13 |
| 2019 | $-17 |
| 2018 | $-27 |
| 2017 | $-32 |
| 2016 | $-28 |
| 2015 | $-22 |
| 2014 | $-17 |
| 2013 | $-10 |
| 2013 | $-0 |
| 2012 | $-14 |
| 2012 | $ |
| 2011 | $ |
| Ekso Bionics Holdings Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-3 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-3 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-4 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-4 |
| 2021-12-31 | $-5 |
| 2021-09-30 | $-3 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-3 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-5 |
| 2019-12-31 | $-3 |
| 2019-09-30 | $-4 |
| 2019-06-30 | $-5 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-6 |
| 2018-06-30 | $-7 |
| 2018-03-31 | $-9 |
| 2017-12-31 | $-8 |
| 2017-09-30 | $-7 |
| 2017-06-30 | $-8 |
| 2017-03-31 | $-8 |
| 2016-12-31 | $-7 |
| 2016-09-30 | $-7 |
| 2016-06-30 | $-7 |
| 2016-03-31 | $-7 |
| 2015-12-31 | $-7 |
| 2015-09-30 | $-5 |
| 2015-06-30 | $-6 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-4 |
| 2013-12-31 | $1 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-0 |
| 2012-09-30 | $-0 |
| 2012-06-30 | $-0 |
| 2012-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.015B | $0.018B |
| Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.480B | 24.70 |
| Intuitive Surgical (ISRG) | United States | $196.045B | 102.50 |
| Alcon (ALC) | Switzerland | $42.794B | 28.63 |
| Edwards Lifesciences (EW) | United States | $42.188B | 26.79 |
| IQVIA Holdings (IQV) | United States | $36.777B | 20.26 |
| IDEXX Laboratories (IDXX) | United States | $35.676B | 42.01 |
| DexCom (DXCM) | United States | $30.357B | 45.72 |
| Waters (WAT) | United States | $22.803B | 33.72 |
| STERIS (STE) | Ireland | $21.310B | 24.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.157B | 0.00 |
| Hologic (HOLX) | United States | $17.098B | 18.47 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.119B | 14.49 |
| Sysmex ADR (SSMXY) | Japan | $13.255B | 0.00 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.105B | 89.18 |
| Masimo (MASI) | United States | $9.091B | 43.99 |
| Teleflex (TFX) | United States | $8.576B | 13.68 |
| Glaukos (GKOS) | United States | $7.735B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.949B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.675B | 26.50 |
| Veracyte (VCYT) | United States | $3.420B | 102.63 |
| Inari Medical (NARI) | United States | $2.990B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.699B | 15.58 |
| Nihon Kohden (NHNKY) | Japan | $2.361B | 17.93 |
| TransMedics (TMDX) | United States | $2.291B | 72.62 |
| Elekta AB (EKTAY) | Sweden | $2.165B | 19.47 |
| Tandem Diabetes Care (TNDM) | United States | $1.978B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| RxSight (RXST) | United States | $1.739B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.365B | 0.00 |
| Artivion (AORT) | United States | $1.243B | 82.39 |
| Pulse Biosciences (PLSE) | United States | $1.215B | 0.00 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.849B | 14.43 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
| IRadimed (IRMD) | United States | $0.687B | 37.11 |
| Mesa Laboratories (MLAB) | United States | $0.674B | 15.88 |
| AxoGen (AXGN) | United States | $0.656B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.512B | 30.12 |
| Treace Medical Concepts (TMCI) | United States | $0.494B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.439B | 23.75 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| CVRx (CVRX) | United States | $0.327B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.174B | 0.00 |
| Nevro (NVRO) | United States | $0.157B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.145B | 15.49 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.095B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| 908 Devices (MASS) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |